A. Fuller

A Phase II Study of the MDR Inhibitor Biricodar (INCEL, VX-710) and Paclitaxel in Women with Advanced Ovarian Cancer Refractory to Paclitaxel Therapy

Michael V. Seiden, Kenneth D. Swenerton, Ursula A. Matulonis et al. · Gynecologic Oncology · 2002 · 98 citations

Mdr Inhibitor Biricodar, Medicine, Metronomic Therapy +9

Abdominal radical trachelectomy: Success and pitfalls in a general gynecologic oncology practice

Alexander Olawaiye, Marcela G. del Carmen, Rosemary Tambouret et al. · Gynecologic Oncology · 2009 · 57 citations

Gynecologic Surgery, Surgical Oncology, Gynecological Surgery +9

Referral of patients with a family history of breast/ovarian cancer--GPs' knowledge and expectations

Peter W. Rose, Eila Watson, P Yudkin et al. · Family Practice · 2001 · 52 citations

Reclassification of a tubal leiomyosarcoma as an eGIST by molecular evaluation of c-KIT

Rosemary Foster, Steven M. Solano, Jennifer Mahoney et al. · Gynecologic Oncology · 2006 · 37 citations

Tubal Leiomyosarcoma, Tumoral Pathology, Medicine +7

A new prognostic model for FIGO stage 1 epithelial ovarian cancer

Andreas Obermair, A. Fuller, Elisa López‐Varela et al. · Gynecologic Oncology · 2006 · 34 citations

Epithelial Ovarian Cancer, New Prognostic Model, Medicine +9